Press Releases

Year None20242023

August 06, 2024

Black Diamond Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update

June 01, 2024

Black Diamond Therapeutics Presents Promising BDTX-1535 Clinical Data in Patients with Recurrent Glioblastoma at 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

May 29, 2024

Black Diamond Therapeutics to Participate in Jefferies Global Healthcare Conference

May 09, 2024

Black Diamond Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update

April 24, 2024

Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

April 11, 2024

Black Diamond Therapeutics Announces Changes to Board of Directors

April 07, 2024

Black Diamond Therapeutics Presents Novel Real-World Evidence of the Evolving EGFR Mutation Landscape in NSCLC and the Opportunity for BDTX-1535 in an Oral Presentation at the 2024 American Association of Cancer Research Annual Meeting

April 03, 2024

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences

March 12, 2024

Black Diamond Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

March 05, 2024

Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024

Displaying 1 - 10 of 12